Echinacea :: Cold-Season Cure or Risk – antimicrobial effects of echinacea

When sneezing and a prickly throat signal an oncoming cold, many people reach for what they believe will be a safe preventative ? a tea or capsule containing echinacea. In the first study to examine the effects of a botanical supplement on bacteria in the gastrointestinal tract, research at the University of Arkansas suggests people may be risking some unwelcome side effects with this common herbal remedy.

Healthcare :: Licensing Opportunities for Rare Disease Technologies

The National Institutes of Health (NIH) launched a new website today offering technologies available for commercial licensing that are related to rare diseases or conditions. The listing can be found at http://www.ott.nih.gov/rarediseases and currently consists of more than 500 such technologies, including drugs, biologics, and devices, available to be transferred from the NIH and the U.S. Food and Drug Administration (FDA) to the private sector for further research and development and potential commercialization.

RNA :: Hairpins for switches

How does an organism know when it must produce a protein and in what amount? Clever control mechanisms are responsible for the regulation of protein biosynthesis. One such type of mechanism, discovered only a few years ago, is riboswitches, which function as a sort of “off” switch for the production of certain proteins.

November/December 2006 Annals of Family Medicine tip sheet

This tip sheet provides summaries of the studies published in the November/December issue of Annals of Family Medicine and cover topics such as antibiotic use for rhinosinusitis and sore throat, the impact of the 2004 flu vaccine shortage and other clinical topics.

Genome :: DOE JGI releases IMG 2.0 with all genomes refreshed from RefSeq

Version 2.0 of the Integrated Microbial Genomes (IMG) data management system of the U.S. Department of Energy Joint Genome Institute has been released to the public. The content of IMG 2.0 has been entirely refreshed and extended with the latest versions of genomes available from the National Center for Biotechnology Information’s (NCBI) Reference Sequence collection (RefSeq).

Anthrax :: New finding points way to foiling anthrax’s tricks

Anthrax, when inhaled, is nearly always fatal, in part because the bacteria have a very effective way of stealing iron from human cells to reproduce. This involves two molecules, siderophores, that compete with the body’s own iron-transport molecules. UC Berkeley researchers have now found that humans produce a protein that sidelines one of these siderophores, but not the other. A drug that blocks the second siderophore should be able to stop anthrax in its tracks.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack